G-Protein coupled receptors

SCIENTIFIC ANIMATION

G-protein coupled receptors (GPCRs) are an attractive drug target; however, not enough is known about their structure, as they are too unstable to isolate and purify. This medical animation highlights the important role they play in many physiological functions and diseases.

Hosted on the homepage of the Sosei Heptares website, the animation introduces a new method developed by Sosei Heptares, of maintaining the structure of GPCRs following their isolation. This method allows for the more effective assessment of drug candidates, highlighting how this technology may be used to develop new treatments for various diseases, including Alzheimer’s disease and cancer.

Are you interested in seeing how our award-winning medical animation can help you?

Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.

TESTIMONIALS

cellectar logo

‘‘Extremely happy, everybody was great on the team. They answered all our questions and made it look easy. The end result is perfect.
Executive Coordinator, Cellectar Biosciences

vallum-logo

‘‘The presentation was dramatically enhanced by the video, which looked fantastic on the big screen. Thank you and the entire Random42 team for your excellent work and for getting the final edition to me in time for the conference. All very much appreciated!
President and CEO, Vallum Corporation

‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics

Amgen Logo

‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen